These should be used according to package instructions and with awareness of any contraindications
Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD
Patients taking tirzepatide 10 mg achieved an average of 19.5% weight loss, and patients taking tirzepatide 15 mg achieved an average of 20.9% weight loss
In our cohort, the majority of patients exhibited active IIH, especially in the UCWM group with significantly shorter disease duration, with slightly higher yet not significant change in the pRNFL thickness in this group
Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: a nationwide, population-based cohort Study
In mouse models, administration of purified P9 protein improved glucose homeostasis and reduced metabolic disease markers